Diagnostic imaging of cervical intraepithelial neoplasia based on hematoxylin and eosin fluorescence

Diagn Pathol. 2015 Jul 25:10:119. doi: 10.1186/s13000-015-0343-8.

Abstract

Background: Pathological classification of cervical intraepithelial neoplasia (CIN) is problematic as it relies on subjective criteria. We developed an imaging method that uses spectroscopy to assess the fluorescent intensity of cervical biopsies derived directly from hematoxylin and eosin (H&E) stained tissues.

Methods: Archived H&E slides were identified containing normal cervical tissue, CIN I, and CIN III cases, from a Community Hospital and an Academic Medical Center. Cases were obtained by consensus review of at least 2 senior pathologists. Images from H&E slides were captured first with bright field illumination and then with fluorescent illumination. We used a Zeiss Axio Observer Z1 microscope and an AxioVision 4.6.3-AP1 camera at excitation wavelength of 450-490 nm with emission captured at 515-565 nm. The 32-bit grayscale fluorescence images were used for image analysis.

Results: We reviewed 108 slides: 46 normal, 33 CIN I and 29 CIN III. Fluorescent intensity increased progressively in normal epithelial tissue as cells matured and advanced from the basal to superficial regions of the epithelium. In CIN I cases this change was less prominent as compared to normal. In high grade CIN lesions, there was a slight or no increase in fluorescent intensity. All groups examined were statistically different.

Conclusion: Presently, there are no markers to help in classification of CIN I-III lesions. Our imaging method may complement standard H&E pathological review and provide objective criteria to support the CIN diagnosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Algorithms
  • Coloring Agents
  • Cytodiagnosis / methods
  • Diagnostic Imaging / methods
  • Eosine Yellowish-(YS)
  • Female
  • Hematoxylin
  • Humans
  • Image Interpretation, Computer-Assisted / methods*
  • Spectrometry, Fluorescence / methods*
  • Uterine Cervical Dysplasia / classification
  • Uterine Cervical Dysplasia / diagnosis*
  • Uterine Cervical Neoplasms / classification
  • Uterine Cervical Neoplasms / diagnosis*

Substances

  • Coloring Agents
  • Eosine Yellowish-(YS)
  • Hematoxylin